TP53 Mutational Analysis Enhances the Prognostic Accuracy of IHC4 and PAM50 Assays

IHC4 and PAM50 assays have been shown to provide additional prognostic information for patients with early breast cancer. We evaluated whether incorporating TP53 mutation analysis can further enhance their prognostic accuracy. We examined TP53 mutation and the IHC4 score in tumors of 605 patients di...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Ching-Hung, Chen, I-Chiun, Huang, Chiun-Sheng, Hu, Fu-Chang, Kuo, Wen-Hung, Kuo, Kuan-Ting, Wang, Chung-Chieh, Wu, Pei-Fang, Chang, Dwan-Ying, Wang, Ming-Yang, Chang, Chin-Hao, Chen, Wei-Wu, Lu, Yen-Shen, Cheng, Ann-Lii
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2015
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4680865/
https://www.ncbi.nlm.nih.gov/pubmed/26671300
http://dx.doi.org/10.1038/srep17879

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4680865/
https://www.ncbi.nlm.nih.gov/pubmed/26671300
http://dx.doi.org/10.1038/srep17879

Ejemplares similares